FDA Warning Letter — Burzynski Research Institute
The FDA took a Warning Letter action against Burzynski Research Institute on December 3, 2013 (Houston, TX). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Burzynski Research Institute
- Date
- December 3, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Center
- CDER
- Location
- Houston, TX (United States)